-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, MSpubIDl/7aYV1ySuIPxCDRARXnkpz+ZUhcQUJe/0Aqer3Qw78UZRhXIWWiaklfJ JKSGMwQCkqeeRjedPNhYGw== 0001032210-99-000047.txt : 19990128 0001032210-99-000047.hdr.sgml : 19990128 ACCESSION NUMBER: 0001032210-99-000047 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19990127 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: BIOJECT MEDICAL TECHNOLOGIES INC CENTRAL INDEX KEY: 0000810084 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 931099680 STATE OF INCORPORATION: OR FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: SEC FILE NUMBER: 005-40150 FILM NUMBER: 99513958 BUSINESS ADDRESS: STREET 1: 7620 S W BRIDGEPORT RD CITY: PORTLAND STATE: OR ZIP: 97224 BUSINESS PHONE: 5036397221 MAIL ADDRESS: STREET 1: 7620 S W BRIDGEPORT ROAD CITY: PORTLAND STATE: OR ZIP: 97224 FORMER COMPANY: FORMER CONFORMED NAME: BIOJECT MEDICAL SYSTEMS LTD DATE OF NAME CHANGE: 19920703 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: DESPAIN & COBY INC/OR CENTRAL INDEX KEY: 0000936314 STANDARD INDUSTRIAL CLASSIFICATION: [] FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 1011 SW EMKAY DRIVE #103 CITY: BAND STATE: OR ZIP: 97702 BUSINESS PHONE: 9413830000 MAIL ADDRESS: STREET 1: 1011 SW EMKAY DRIVE #103 CITY: BEND STATE: OR ZIP: 97702 SC 13G/A 1 SCHEDULE 13G FOR DESPAIN & COBY LLC CUSIP No. 09059T107 13G Page 1 of 5 Pages SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G/A AMENDMENT NO. 2 INFORMATION STATEMENT PURSUANT TO RULES 13d-1 AND 13d-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934 1 Bioject Medical Technologies Inc. ------------------------------------------------------------- (Name of Issuer) Common Stock --------------------------------------------------- (Title of Class of Securities) 09059T107 ----------------------------------------- (CUSIP Number) Jan. 19, 1999 _______________________________ (Date of Event Which Requires Filing of This Statement) Check the Appropriate box to designate the rule pursuant to which this schedule is filed: [ ] Rule 13d-1 (b) [X] Rule 13d-1 (c) [ ] Rule 13d-1 (d) 1 The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP NO. 09059T107 13G Page 2 of 5 Pages NAME OF REPORTING PERSONS 1 S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS DeSpain & Coby, Inc. Tax ID# 93-1157255 - ------------------------------------------------------------------------------ 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [_] (b) [X] - ------------------------------------------------------------------------------ 3 SEC USE ONLY - ------------------------------------------------------------------------------ 4 CITIZENSHIP OR PLACE OF ORGANIZATION Oregon - ------------------------------------------------------------------------------ 5 SOLE VOTING POWER NUMBER OF 0 SHARES ----------------------------------------------------------- SHARED VOTING POWER BENEFICIALLY 6 1,428,224 OWNED BY ----------------------------------------------------------- EACH SOLE DISPOSITIVE POWER 7 REPORTING 0 PERSON ----------------------------------------------------------- SHARED DISPOSITIVE POWER WITH 8 1,428,224 - ------------------------------------------------------------------------------ AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 9 1,428,224 - ------------------------------------------------------------------------------ CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* 10 [ ] - ------------------------------------------------------------------------------ PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 11 4.9 - ------------------------------------------------------------------------------ TYPE OF REPORTING PERSON* 12 IV - ------------------------------------------------------------------------------ *SEE INSTRUCTION BEFORE FILLING OUT! CUSIP No. 09059T107 13G Page 3 of 5 pages Item 1(a). Name of Issuer: Bioject Medical Technologies Inc. Item 1(b). Address of Issuer's Principal Executive Offices: 7620 SW Bridgeport Road Portland, OR 97224 Item 2(a). Name of Person Filing: DeSpain & Coby, Inc. Item 2(b). Address of Principal Business Office or, if none, Residence: 1001B Disk Drive, #104 Bend, OR 97702 Item 2(c). Citizenship: Oregon Item 2(d). Title of Class of Securities: Common Stock Item 2(e). CUSIP Number: 09059T107 Item 3. If this statement is filed pursuant to Rules 13d-1(b),or 13d-2(b), check whether the person filing is a: (a) [_] Broker or Dealer registered under Section 15 of the Act; (b) [_] Bank as defined in Section 3(a)(6) of the Act; (c) [_] Insurance Company registered under Section 3(a)(19) of Act; (d) [_] Investment Company registered under Section 8 of the Investment Company Act of 1940; (e) [_] Investment Adviser in accordance with Rule 13(d)-1(b)(1)(ii)(E); (f) [_] Employee Benefit Plan or Endowment plan in accordance with Rule 13(d)-1(b)(1)(ii)(F); (g) [_] Parent Holding Company or control person, in accordance with Rule 13d-1(b)(1)(ii)(G); (h) [_] A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act; (i) [_] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940; (j) [_] Group, in accordance with Rule 13d-1(b)(1)(ii)(J) [X] If this statement is filed pursuant to Rule 13d-1(c), check this box. CUSIP No. 09059T107 13G Page 4 of 5 Pages Item 4. Ownership (a) Amount Beneficially Owned: 1,370,084 shares of Common Stock which includes the right to acquire 58,140 shares of Common STock pursuant to a currently exercisable warrant. The fileer is the general partner of two limited partnerships. As general partner, the filer has the sole power to vote or dispose of the shares, as indicated below. Summit Fund Limited Partnership owns 760,912 shares of Common Stock, which includes the right to acquire 29,070 shares of Common Stock pursuant to a currently exercisable warrant. Tiburon Fund Limited Partnership owns 667,312 shares of Common Stock, which includes the right to acqure 29,070 shares of Common Stock pursuant to a currently exercisable warrant. (b) Percent of Class: 4.9% (c) Number of shares as to which such person has: i) sole power to vote or to direct the vote: 1,428,224 ii) shared power to vote or to direct the vote: 0 iii) sole power to dispose or to direct the disposition of: 1,428,224 iv) shared power to dispose or to direct the disposition of: 0 Item 5. Ownership of Five Percent or Less of a Class: If the statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [X]. Item 6. Ownership of More than 5% on Behalf of Another Person: Not Applicable Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. Not Applicable Item 8. Identification and Classification of Members of the Group: Note. If a group has filed this schedule pursuant to Rule 13d-1(b)(1)(ii)(J), so indicate under Item 3(j) and attach an exhibit stating the identity and Item 3 classification of each member of the group. If a group has filed this schedule pursuant to Rule 13d-1(d), attach an exhibit stating the identity of each member of the group. Not Applicable CUSIP No. 09059T107 13G Page 5 of 5 Pages Item 9. Notice of Dissolution of the Group: Not Applicable. Item 10. Certification By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. January 27, 1999 1-27-99 ______________________________________ (Date) DeSpain & Coby, Inc. /s/ Daniel DeSpain /s/ Daniel DeSpain President ______________________________________ (Signature) Daniel DeSpain, President /s/ Daniel DeSpain President ______________________________________ (Name/Title) -----END PRIVACY-ENHANCED MESSAGE-----